Biotech News

Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results

Twist Bioscience Corporation (TWST)Twist Bioscience Corporation2026-06-25 13:46 ESTEarnings

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 4, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the second quarter fiscal 2026 ended March 31, 2026.

Open original release

Related news

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience to Present at Upcoming Investor Conferences

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences

TWSTTwist Bioscience Corporation2026-06-25 13:46 EST

Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026

NRSNNeuroSense Therapeutics2026-06-25 13:46 EST

NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease

View all latest news

Twist Bioscience Corporation

Twist Bioscience is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

Recent company news

TWSTTwist Bioscience Corporation2026-06-26 07:10 EST

Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference

TWSTTwist Bioscience Corporation2026-06-26 07:10 EST

Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue

TWSTTwist Bioscience Corporation2026-06-26 07:10 EST

Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results

TWSTTwist Bioscience Corporation2026-06-26 07:10 EST

Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes

TWSTTwist Bioscience Corporation2026-06-26 07:10 EST

Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States